Folger Hill Asset Management’s Insys Therapeutics, Inc. INSY Stock Holding History

Folger Hill Asset Management’s Portfolio INSY Stock Details INSY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-396,315	Closed	-$3.52M	–	238
2017 Q3	$3.52M	Sell	396,315 -383,968	-49%	-$3.96M	0.31%	95
2017 Q2	$9.87M	Sell	780,283 -225,978	-22%	-$2.67M	0.89%	34
2017 Q1	$10.6M	Sell	1,006,261 -228,228	-18%	-$2.43M	0.85%	31
2016 Q4	$11.4M	Sell	1,234,489 -187,578	-13%	-$2.12M	1.02%	27
2016 Q3	$16.8M	Sell	1,422,067 -175,878	-11%	-$2.67M	1%	22
2016 Q2	$20.7M	Buy	1,597,945 +179,807	+13%	+$2.62M	1.61%	8
2016 Q1	$22.7M	Buy	1,418,138 +418,791	+42%	+$7.95M	1.27%	12
2015 Q4	$28.6M	Buy	+999,347	New	+$27.7M	1.73%	12

Other funds holding INSY

OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 57.61% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

EMG

ETF Managers Group Summit, New Jersey $3.1B AUM 17.12% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Folger Hill Asset Management's INSY Position: Q4 2017 in Review

Folger Hill Asset Management sold out of Insys Therapeutics, Inc. (INSY) in Q4 2017, closing a stake of 396,315 shares — an estimated $3.52M sold.

Folger Hill Asset Management first reported a position in INSY in Q4 2015 and held it in 8 quarters. The position peaked at $28.6M in Q4 2015. 113 funds tracked by Wall St. Rank hold INSY as of Q4 2017.

Folger Hill Asset Management reported no remaining Insys Therapeutics, Inc. position as of Q4 2017 after selling out during the quarter.
Folger Hill Asset Management sold 396,315 Insys Therapeutics, Inc. shares in Q4 2017, an estimated $3.52M.
Folger Hill Asset Management first reported a position in Insys Therapeutics, Inc. in Q4 2015 and held it in 8 quarters.
Folger Hill Asset Management's Insys Therapeutics, Inc. position peaked at $28.6M in Q4 2015.
113 funds tracked by Wall St. Rank held Insys Therapeutics, Inc. as of Q4 2017.

Based on Folger Hill Asset Management's 13F filing for Q4 2017, filed 14 Feb 2018.